Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This is a 55.6% decrease from the number of companies inspected in the previous quarter, when nine companies received nine inspections.
Most of the companies inspected at the time were involved in the Food and Cosmetics sector. Both the Biologics and Devices sectors sectors tied for second most common type.
There were three companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. One should take voluntary action to correct the organization's management operations. Additionally, one company had to take regulatory and/or administrative actions.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
Air Fayre | Food and Cosmetics | 11/04/2024 | No Action Indicated (NAI) |
CSL Plasma, Inc. | Biologics | 10/11/2024 | No Action Indicated (NAI) |
Edge Biologicals, Inc. | Devices | 11/22/2024 | Official Action Indicated (OAI) |
Edge Biologicals, Inc. | Devices | 11/22/2024 | Voluntary Action Indicated (VAI) |
Medline Industries Holdings LP | Food and Cosmetics | 10/28/2024 | No Action Indicated (NAI) |